MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
Neuroptix
Attachments
Neuroptix Corporation
Parents
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Devices, NeuroTechnology, Services & Health Information Technology)
*Industry: Massachusetts
Venture Capital: Series C
Children
Acton, Massachusetts
Investors include Inventages, a life-sciences, nutrition and wellness focused venture capital fund
Neuroptix Closes approximately $4 Million C Round Financing (2011)
Neuroptix is creating and developing an innovative non-invasive and predictive laser eye scanning test for the early detection and diagnosis of Alzheimer’s Disease.
Past Investor(s) Beacon Angels, Quan Ventures, Quan Management, Launchpad Venture Group, Maine Angels, Inventages Venture Capital, Breakfast Club, Granite State Angels
Paul Hartung, President and CEO of Neuroptix
The company brought in $18.5 million in a Series B round of funding in 2008, led by Inventages.